Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I

Tyrosinemia type I (HTI) is treated with nitisinone, a tyrosine (Tyr) and phenylalanine (Phe)-restricted diet, and supplemented with a Tyr/Phe-free protein substitute (PS). Casein glycomacropeptide (CGMP), a bioactive peptide, is an alternative protein source to traditional amino acids (L-AA). CGMP...

Descripción completa

Detalles Bibliográficos
Autores principales: Daly, Anne, Evans, Sharon, Pinto, Alex, Ashmore, Catherine, MacDonald, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467066/
https://www.ncbi.nlm.nih.gov/pubmed/34579102
http://dx.doi.org/10.3390/nu13093224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467066/
https://www.ncbi.nlm.nih.gov/pubmed/34579102
http://dx.doi.org/10.3390/nu13093224

Ejemplares similares